Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-007540
Filing Date
2004-01-22
Accepted
2004-01-22 17:07:00
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO 1 d10ka.htm 10-K/A 1783915
3 CONSENT OF BDO SEIDMAN, LLP dex231.htm EX-23.1 2213
4 CERTIFICATION OF CEO dex311.htm EX-31.1 4720
5 CERTIFICATION OF CFO dex312.htm EX-31.2 4797
6 CERTIFICATION dex321.htm EX-32.1 6395
  Complete submission text file 0001193125-04-007540.txt   1804051
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 04538309
SIC: 2835 In Vitro & In Vivo Diagnostic Substances